Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? . Clinics [Internet]. 2011 Jan. 1 [cited 2024 May 25];66(7):1171-5. Available from: https://revistas.usp.br/clinics/article/view/19356